The store will not work correctly when cookies are disabled.
4-pyridazin-3-yl methylene N'-allyl thiosemicarbazone
ID: ALA113281
PubChem CID: 9579508
Max Phase: Preclinical
Molecular Formula: C9H11N5S
Molecular Weight: 221.29
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: C=CCNC(=S)N/N=C/c1cccnn1
Standard InChI: InChI=1S/C9H11N5S/c1-2-5-10-9(15)14-12-7-8-4-3-6-11-13-8/h2-4,6-7H,1,5H2,(H2,10,14,15)/b12-7+
Standard InChI Key: JGQOMKFNIHTRJF-KPKJPENVSA-N
Molfile:
RDKit 2D
15 15 0 0 0 0 0 0 0 0999 V2000
1.9500 -1.4792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9125 -1.4792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.1333 -0.8792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.9500 -0.8792 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-0.6500 -0.5792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.9042 -0.8792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4292 -1.7792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.3875 -0.5792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4667 -1.7792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.5042 -1.7750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0292 -1.4750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9875 -1.4750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6500 0.0208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3875 0.0208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1333 0.3208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 7 1 0
3 8 2 0
4 1 2 0
5 3 1 0
6 2 2 0
7 1 1 0
8 6 1 0
9 1 1 0
10 12 1 0
11 10 2 0
12 9 1 0
13 15 1 0
14 8 1 0
15 14 2 0
13 5 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 221.29 | Molecular Weight (Monoisotopic): 221.0735 | AlogP: 0.46 | #Rotatable Bonds: 4 |
Polar Surface Area: 62.20 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 11.28 | CX Basic pKa: 1.35 | CX LogP: 1.10 | CX LogD: 1.10 |
Aromatic Rings: 1 | Heavy Atoms: 15 | QED Weighted: 0.33 | Np Likeness Score: -2.58 |
References
1. Easmon J, Heinisch G, Holzer W, Rosenwirth B.. (1992) Novel thiosemicarbazones derived from formyl- and acyldiazines: synthesis, effects on cell proliferation, and synergism with antiviral agents., 35 (17): [PMID:1354751] [10.1021/jm00095a027] |